Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Thyrotropin releasing factor measurement |
Has measured component |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Thyrotropin releasing factor measurement |
Component |
True |
Thyrotropin releasing factor |
Inferred relationship |
Some |
1 |
Allergy to thyrotropin releasing factor |
Causative agent |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Allergy to protirelin |
Causative agent |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Allergy to thyrotrophin (finding) |
Causative agent |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
protirelin 100 µg/ml injektionsvæske, opløsning, ampul a 2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Product containing thyrotrophin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Product containing thyrotropin releasing factor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thyrotropin releasing factor |
Inferred relationship |
Some |
1 |
protirelin 500 µg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
thyrotropin alfa 1,1 mg/hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Product containing thyrotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
thyrotropin alfa 0,9 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
thyrotropinfrigørende faktor-middel |
Is a |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Thyrotropin releasing factor adverse reaction (disorder) |
Causative agent |
True |
Thyrotropin releasing factor |
Inferred relationship |
Some |
1 |
Product containing thyrotropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
|
Allergy to thyrotropin releasing factor |
Causative agent |
True |
Thyrotropin releasing factor |
Inferred relationship |
Some |
1 |
Radionuclide imaging of thyroid with administration of thyrotropin releasing hormone (procedure) |
Using substance (attribute) |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
1 |
Protirelin adverse reaction |
Causative agent |
False |
Thyrotropin releasing factor |
Inferred relationship |
Some |
2 |
Product containing only thyrotropin releasing factor (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Thyrotropin releasing factor |
Inferred relationship |
Some |
1 |
Radionuclide imaging of thyroid with administration of thyrotropin releasing hormone (procedure) |
Direct substance |
True |
Thyrotropin releasing factor |
Inferred relationship |
Some |
1 |